GTx, Inc. (Nasdaq: GTXI) announced today a webcast discussing Capesaris®(GTx-758) and it’s potential role in the treatment of advanced prostate cancer in men is scheduled for Friday, February 15^th 2013, from 9:00am – 10:00am Eastern Time. The presentations will be conducted by an expert faculty panel to include: Phillip Kantoff, MD, Dana-Farber Cancer Institute/Brigham and Women’s Hospital; Thomas Flaig, MD, University of Colorado School of Medicine; and Evan Yu, MD, Fred Hutchinson Cancer Research Center.

Register for the live webcast at (http://www.media-server.com/m/p/tseh66fk [2]).